MedTrace Logo

Continuous Positive Airway Pressure to Improve Milder Obstructive Sleep Apnea

NCT00089752 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 281

Last updated 2017-07-24

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to determine whether functional status improves in individuals with milder obstructive sleep apnea (OSA) following continuous positive airway pressure (CPAP) treatment.

Conditions

Interventions

DEVICE

Continuous Positive Airway Pressure (CPAP) Treatment

CPAP device used at night

DEVICE

Sham CPAP device - CPAP device with pressure delivered <1 cm H20

Sham CPAP device used at night

Sponsors & Collaborators

  • National Heart, Lung, and Blood Institute (NHLBI)

    collaborator NIH

  • Respironics Sleep and Respiratory Foundation

    collaborator UNKNOWN

  • Cephalon

    collaborator INDUSTRY

  • University of Pennsylvania

    lead OTHER

Principal Investigators

  • Terri Weaver · University of Pennsylvania

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-09-30
Primary Completion
2008-08-31
Completion
2008-11-30

Countries

  • United States
  • Canada

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00089752 on ClinicalTrials.gov